Form 4: BrightSpring Health Services CEO Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


BrightSpring Health Services CEO, Jon B. Rousseau, sold 44,362 shares to cover tax obligations related to vesting restricted stock units.

Summary

  • Jon B. Rousseau, CEO of BrightSpring Health Services, sold 44,362 shares of common stock on January 25, 2025, at a price of $22.82 per share.
  • This sale was to cover tax obligations arising from the vesting of 80,657 restricted stock units (RSUs).
  • Following the transaction, Rousseau directly owns 887,596 shares and indirectly owns 369,763 shares through the Rousseau Family Trust.
  • The directly owned shares include 645,256 shares underlying RSUs that will vest in eight equal quarterly installments starting April 25, 2025.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by an executive. It doesn't indicate any positive or negative sentiment about the company's performance.

Future Outlook

The document indicates that 645,256 shares underlying RSUs will vest in eight equal quarterly installments commencing on April 25, 2025.

Management Comments

  • The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.

Industry Context

This is a standard Form 4 filing, which is common for corporate insiders when they buy or sell company stock. It is a routine disclosure and does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
  • The sale of shares to cover tax obligations is a common practice among executives who receive stock-based compensation.
  • The vesting schedule of the RSUs is also a typical arrangement for executive compensation packages.

Stakeholder Impact

  • The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant given the reason for the sale.

Next Steps

  • The remaining RSUs will continue to vest quarterly starting April 25, 2025.

Key Dates

DateDescription
01/25/2025Date of the stock sale transaction.
01/24/2025Closing stock price used to calculate the net settlement price for the RSUs.
04/25/2025Start date for the quarterly vesting of 645,256 RSUs.
01/28/2025Date the form was signed.

Keywords

BrightSpring Health Services, Jon B. Rousseau, stock sale, restricted stock units, tax obligations, insider trading, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.